(Q48647471)

13 February 2018

title

Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. (English)

1 reference

13 February 2018

0 references

1

Roy W Beck

1 reference

13 February 2018

author name string

Danielle L Chandler

2

1 reference

13 February 2018

Stephen R Cole

3

1 reference

13 February 2018

Jack H Simon

4

1 reference

13 February 2018

Lawrence D Jacobs

5

1 reference

13 February 2018

R Philip Kinkel

6

1 reference

13 February 2018

John B Selhorst

7

1 reference

13 February 2018

John W Rose

8

1 reference

13 February 2018

Joanna A Cooper

9

1 reference

13 February 2018

George Rice

10

1 reference

13 February 2018

Thomas J Murray

11

1 reference

13 February 2018

Alfred W Sandrock

12

1 reference

13 February 2018

publication date

1 April 2002

1 reference

13 February 2018

published in

Annals of Neurology

1 reference

13 February 2018

volume

51

1 reference

13 February 2018

page(s)

481-490

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

cites work

1 reference

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

21 January 2018

1 reference

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

Multisequence MRI in clinically isolated syndromes and the early development of MS.

21 January 2018

1 reference

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

21 January 2018

1 reference

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

21 January 2018

1 reference

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination.

21 January 2018

1 reference

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10148

1 reference

13 February 2018

PubMed ID

11921054

1 reference

13 February 2018